1·The subject of the invention is to develop silybin glucoside solution with excellent coloring stability.
本发明的课题是开发着色稳定性优异的水飞蓟宾糖苷溶液。
2·The pharmacodynamic result shows that 7-site substituted dehydrogenized silybin ether can be expectantly used for preparing the medicament for preventing and treating the neurodegenerative diseases.
药效学结果表明该7位取代脱氢水飞蓟宾醚化合物可以预期用于制备防治神经退行性疾病类药物的用途。
3·OBJECTIVE: To establish an HPLC method for the assaying of silybin in Gantai capsule.
目的建立以高效液相色谱法测定肝泰胶囊中水飞蓟宾含量的方法。